Pascal Colosetti
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- TGF-β signaling in diseases
- Cell death mechanisms and regulation
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Cell death mechanisms and regulation 6
- Extracellular vesicles in disease 5
- TGF-β signaling in diseases 4
- Ubiquitin and proteasome pathways 3
- Epidemiology 10
- Autophagy in Disease and Therapy 9
- Co-authors
- Patrick Auberger (22 shared papers)Kohei Miyazono (5 shared papers)Anders Olofsson (2 shared papers)Carl‐Henrik Heldin (2 shared papers)Arnaud Jacquel (13 shared papers)Frédéric Luciano (8 shared papers)Frédéric Bost (2 shared papers)Issam Ben Sahra (2 shared papers)
- Journals
- Oncogene (7 papers)Autophagy (3 papers)Leukemia (3 papers)BioMed Research International (2 papers)PLoS ONE (2 papers)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Pascal Colosetti
48 papers receiving 3.3k citations
Pascal Colosetti's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 501
- Molecular Biology 2.3k
- Hematology 330
- Immunology and Allergy 151
- Oncology 612
Countries citing papers authored by Pascal Colosetti
This map shows the geographic impact of Pascal Colosetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Colosetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Colosetti more than expected).
Fields of papers citing papers by Pascal Colosetti
This network shows the impact of papers produced by Pascal Colosetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Colosetti. The network helps show where Pascal Colosetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Colosetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Hit paper breakdown → | 2008 | 732 |
| 2 | 1991 | 426 | |
| 3 | 2003 | 396 | |
| 4 | 1992 | 161 | |
| 5 | 2004 | 149 | |
| 6 | 2020 | 124 | |
| 7 | 2015 | 106 | |
| 8 | 2015 | 99 | |
| 9 | 2009 | 78 | |
| 10 | 2009 | 74 | |
| 11 | 2005 | 68 | |
| 12 | 2009 | 67 | |
| 13 | 2004 | 66 | |
| 14 | 2008 | 58 | |
| 15 | 2015 | 54 | |
| 16 | 1999 | 49 | |
| 17 | 2012 | 47 | |
| 18 | 2014 | 42 | |
| 19 | 2006 | 40 | |
| 20 | 2003 | 39 |
About Pascal Colosetti
Pascal Colosetti is a scholar working on Molecular Biology, Epidemiology, Hematology, Genetics and Oncology, having authored 48 papers that have together received 3.3k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cell death mechanisms and regulation (6 papers), Extracellular vesicles in disease (5 papers), TGF-β signaling in diseases (4 papers), Organ Transplantation Techniques and Outcomes (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (501 citations), Molecular Biology (2.3k citations), Hematology (330 citations), Immunology and Allergy (151 citations) and Oncology (612 citations). Pascal Colosetti has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Patrick Auberger, Kohei Miyazono, Anders Olofsson, Carl‐Henrik Heldin, Arnaud Jacquel, Frédéric Luciano, Frédéric Bost, Issam Ben Sahra, Magali Herrant and Y. Le Marchand‐Brustel. Their work appears in journals such as Oncogene, Autophagy, Leukemia, BioMed Research International and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.